Penconazole is a triazole fungicide that is widely used to control a variety of fungal diseases in a variety of crops, including fruits, vegetables, and cereals. It is effective against a broad spectrum of fungal pathogens, including powdery mildew, rust, and leaf spot diseases. Penconazole works by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes. This disruption of fungal cell membrane integrity leads to cell death and prevents the spread of fungal infection. Penconazole is applied to crops as a foliar spray, and it is also available as a seed treatment. It is absorbed by the plant and translocated throughout the plant tissue, providing protection against fungal infections. Penconazole has been shown to be effective in controlling a variety of fungal diseases in a variety of crops, and it is considered to be a safe and effective fungicide. Penconazole is synthesized from the reaction of 1-(4-chlorophenyl)-4,4-dimethylpentan-3-one with 2-(2,4-dichlorophenyl)-1H-imidazole-1-methanol. Penconazole is studied because it is an important fungicide for controlling fungal diseases in crops, and because it is a potent inhibitor of fungal growth.'
penconazole: structure given in first source
penconazole : A racemate comprising equal amounts of (R)- and (S)-penconazole. A fungicide used to control powdery mildew, scab and other pathogenic Ascomycetes, Basidiomycetes and Deuteromycetes.
1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole : A member of the classof triazoles that is 1,2,4-triazole substituted at position 1 by a 2-(2,4-dichlorophenyl)pentyl group.
ID Source | ID |
---|---|
PubMed CID | 91693 |
CHEMBL ID | 481474 |
CHEBI ID | 83993 |
CHEBI ID | 81970 |
SCHEMBL ID | 24791 |
MeSH ID | M0230655 |
Synonym |
---|
AC-12494 |
NCGC00166157-01 |
penconazole |
topaze |
cga 71818 |
1-(2-(2,4-dichlorophenyl)pentyl)-1h-1,2,4-triazole |
penconazole [bsi:iso] |
topaze c |
onmex |
einecs 266-275-6 |
1h-1,2,4-triazole, 1-(2-(2,4-dichlorophenyl)pentyl)- |
brn 0541488 |
1-(2,4-dichloro-beta-propylphenethyl)-1h-1,2,4-triazole |
66246-88-6 |
topas |
CHEMBL481474 |
chebi:83993 , |
1-[2-(2,4-dichlorophenyl)pentyl]-1,2,4-triazole |
C18801 |
award |
topaz |
dtxsid8042260 , |
cas-66246-88-6 |
dtxcid6022260 |
tox21_301318 |
NCGC00255892-01 |
unii-3un9f9zj43 |
3un9f9zj43 , |
5-26-01-00149 (beilstein handbook reference) |
penconazol |
FT-0630762 |
AKOS015906183 |
1-(2-(2,4-dichlorophenyl)pentyl)-1h-1,2,4-triazole, (+/-)- |
topaz [inci] |
cga-71818 |
penconazole [mi] |
penconazole [iso] |
(rs)-1-(2-(2,4-dichlorophenyl)-n-pentyl)-1h-1,2,4-triazole |
1-[2-(2,4-dichlorophenyl)pentyl]-1h-1,2,4-triazole |
1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole |
SCHEMBL24791 |
1-[2-(2,4-dichlorophenyl)-pentyl]-1h-1,2,4-triazole |
1h-1,2,4-triazole, 1-[2-(2,4-dichlorophenyl)pentyl]- |
topas 100 |
(+-)-penconazole |
penconazol, pestanal(r), analytical standard |
penconazole 100 microg/ml in acetonitrile |
penconazole 10 microg/ml in cyclohexane |
1-[2-(2,4-dichlorophenyl)-n-pentyl]-1h-1,2,4-triazole |
E76108 |
mfcd00078737 |
Q2426626 |
AS-14842 |
CS-0113947 |
HY-135761 |
rac-1-(2-(2,4-dichlorophenyl)pentyl)-1h-1,2,4-triazole |
gold topaz |
chebi:81970 |
gold topaz8121 |
rac-penconazole |
(rs)-penconazole |
racemic penconazole |
Penconazole (PEN) is a widely used systemic fungicide to treat various fungal diseases in plants. It leaves residues in crops and food products causing serious environmental and health problems. Penconazol is toxic to a variety of organisms including fish.
Penconazole is a widely used fungicide that is toxic to a variety of organisms including fish. The results showed that penconazol exposure caused adverse effects on zebrafish embryos, such as autonomous motor abnormalities and heart rate slowing.
Excerpt | Reference | Relevance |
---|---|---|
"This study investigated the effects of sugarcane bagasse compost (SBC) and chicken manure compost (CMC) on the sorption-desorption, leaching and bioavailability of the fungicide penconazole in soil in a laboratory setting." | ( Effects of two different organic amendments addition to soil on sorption-desorption, leaching, bioavailability of penconazole and the growth of wheat (Triticum aestivum L.). Jia, LX; Jiang, L; Lin, JL; Lin, Y; Liu, Y; Pan, B; Yang, Y, 2016) | 0.84 |
Class | Description |
---|---|
dichlorobenzene | Any member of the class of chlorobenzenes carrying two chloro groups at unspecified positions. |
triazoles | An azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 45.5011 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521; AID1159523 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 21.2588 | 0.0007 | 14.5928 | 83.7951 | AID1259369; AID1259392 |
AR protein | Homo sapiens (human) | Potency | 42.8106 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243; AID1259247; AID743035; AID743042; AID743054; AID743063 |
estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 30.6379 | 0.0006 | 57.9133 | 22,387.1992 | AID1259378 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 50.9934 | 0.0010 | 22.6508 | 76.6163 | AID1224839; AID1224893 |
progesterone receptor | Homo sapiens (human) | Potency | 19.3312 | 0.0004 | 17.9460 | 75.1148 | AID1346795 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 48.9662 | 0.0002 | 14.3764 | 60.0339 | AID720692 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 67.2985 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 44.9342 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 30.6379 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 54.9410 | 0.3758 | 27.4851 | 61.6524 | AID743217 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 24.3365 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 56.8000 | 0.0002 | 29.3054 | 16,493.5996 | AID1259244; AID1259248; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 61.6448 | 0.0010 | 19.4141 | 70.9645 | AID743191 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 12.1972 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 67.2985 | 0.0016 | 28.0151 | 77.1139 | AID1259385; AID1259395 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 39.1533 | 0.0578 | 21.1097 | 61.2679 | AID1159526; AID1159528 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 59.9798 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 31.5456 | 0.0006 | 27.2152 | 1,122.0200 | AID743202; AID743219 |
Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 54.4827 | 0.0015 | 57.7890 | 15,848.9004 | AID1259244 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 69.9313 | 0.0023 | 19.5956 | 74.0614 | AID651631; AID720552 |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 54.4827 | 0.0015 | 51.7393 | 15,848.9004 | AID1259244 |
ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 43.2771 | 0.0119 | 17.9420 | 71.5630 | AID651632 |
Ataxin-2 | Homo sapiens (human) | Potency | 43.2771 | 0.0119 | 12.2221 | 68.7989 | AID651632 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1111070 | Antifungal activity against Podosphaera aphanis isolate BRE in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340954 | Antifungal activity against Candida glabrata ATCC 90030 by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340963 | Antifungal activity against Cryptococcus neoformans ATCC 90112 by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111056 | Antifungal activity against Podosphaera aphanis isolate SAG in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111068 | Antifungal activity against Podosphaera aphanis isolate DAR1 in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111065 | Antifungal activity against Podosphaera aphanis isolate GUI in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111061 | Antifungal activity against Podosphaera aphanis isolate MAR in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111064 | Antifungal activity against Podosphaera aphanis isolate HOR in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111055 | Antifungal activity against Podosphaera aphanis isolate SIL in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340956 | Antifungal activity against Candida krusei ATCC 6258 by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111060 | Antifungal activity against Podosphaera aphanis isolate MEG in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111058 | Antifungal activity against Podosphaera aphanis isolate PAJ in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340950 | Antifungal activity against Candida albicans isolates from HIV infected patient during fluconazole therapy by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111066 | Antifungal activity against Podosphaera aphanis isolate DOU in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340955 | Antifungal activity against Candida krusei isolates from grapes and feeding stuffs by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111074 | Antifungal activity against Podosphaera aphanis isolate ABA in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111054 | Antifungal activity against Podosphaera aphanis isolate SOC in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340965 | Antifungal activity against sKloeckera apiculata isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID341133 | Antifungal activity against sSaccharomyces cerevisiae isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111051 | Antifungal activity against Podosphaera aphanis isolate VIR in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111059 | Antifungal activity against Podosphaera aphanis isolate MEP in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111067 | Antifungal activity against Podosphaera aphanis isolate DAR18 in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111052 | Antifungal activity against Podosphaera aphanis isolate SOU in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340966 | Antifungal activity against Rhodotorula sp. isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111071 | Antifungal activity against Podosphaera aphanis isolate BRA in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111062 | Antifungal activity against Podosphaera aphanis isolate LI1 in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111063 | Antifungal activity against Podosphaera aphanis isolate LBP in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111073 | Antifungal activity against Podosphaera aphanis isolate AVI in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340962 | Antifungal activity against sCandida stellata isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111072 | Antifungal activity against Podosphaera aphanis isolate ART in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID1111069 | Antifungal activity against Podosphaera aphanis isolate CAM in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340949 | Antifungal activity against Candida albicans isolates from HIV infected patient before fluconazole therapy by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340961 | Antifungal activity against Candida albidus isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340952 | Antifungal activity against Candida albicans isolates by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID1111057 | Antifungal activity against Podosphaera aphanis isolate PES in Darselect leaf disks after 8 days | 2010 | Pest management science, Jan, Volume: 66, Issue:1 | Sensitivity of Podosphaera aphanis isolates to DMI fungicides: distribution and reduced cross-sensitivity. |
AID340957 | Antifungal activity against Candida lambica isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340951 | Antifungal activity against Candida albicans isolates from animals by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340953 | Antifungal activity against Candida glabrata isolates from feeding stuffs by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID341134 | Antifungal activity against Saccharomycopsis guttulata isolates from feeding stuff by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340960 | Antifungal activity against Candida rugosa isolates from feeding stuff by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340958 | Antifungal activity against Candida norvegensis isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340959 | Antifungal activity against Candida parapsilosis ATCC 22013 by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
AID340964 | Antifungal activity against Pichia anomala isolates from grapes by NCCLS M27-A2 method | 2007 | Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8 | Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (4.23) | 18.2507 |
2000's | 17 (23.94) | 29.6817 |
2010's | 35 (49.30) | 24.3611 |
2020's | 16 (22.54) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (40.77) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (1.41%) | 6.00% |
Case Studies | 1 (1.41%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 69 (97.18%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |